Joint reasoned statement of the Management Board and the Supervisory Board of APONTIS PHARMA AG on the voluntary public purchase offer of Zentiva AG Read more
Address
APONTIS PHARMA Deutschland GmbH & Co. KG
Rolf-Schwarz-Schütte-Platz 1
40789 Monheim am Rhein (Germany)

Tel. +49 2173 8955 4949
Fax +49 2173 8955 4941 
E-mail: info@apontis-pharma.de
Company Data
Local court, office, management, bank...
Amtsgericht (Local Court) of Düsseldorf
commercial register office No. (HRA) 23282
commercial register No. (HRB) 241128
UST-ID: DE300714101

Personally liable partner: APONTIS PHARMA Deutschland GmbH

Seat of the company: Monheim
CEO: Bruno Wohlschlegel (Chairman / CEO), Thomas Milz, Thomas Zimmermann

SWIFT/BIC: HYVEDEMMXX
IBAN: DE32 7002 0270 0020 1819 67
Conception, Screen Design & Programming
emit gmbh